Mediators of Inflammation

Mediators of Inflammation / 2019 / Article

Erratum | Open Access

Volume 2019 |Article ID 8419439 | https://doi.org/10.1155/2019/8419439

Ying Zhang, Rong Cao, Haijian Ying, Juping Du, Shuaishuai Chen, Na Wang, Bo Shen, "Erratum to “Increased Expression of TLR10 in B Cell Subsets Correlates with Disease Activity in Rheumatoid Arthritis”", Mediators of Inflammation, vol. 2019, Article ID 8419439, 2 pages, 2019. https://doi.org/10.1155/2019/8419439

Erratum to “Increased Expression of TLR10 in B Cell Subsets Correlates with Disease Activity in Rheumatoid Arthritis”

Received23 Jan 2019
Accepted27 Jan 2019
Published10 Mar 2019

In the article titled “Increased Expression of TLR10 in B Cell Subsets Correlates with Disease Activity in Rheumatoid Arthritis” [1], the email address of the corresponding author Bo Shen should be corrected as “shenbkz@aliyun.com.” In addition, the format of Table 1 was incorrect. This occurred due to a production error. The corrected Table is shown below.


Healthy control group ()All RA group ()Low active RA group ()Moderate active RA group ()High active RA group ()

Female (%)26 (86.7)66 (85.7)16 (84.2)25 (86.2)25 (86.2)
Age (years)
Disease duration (years)5.0 (2-12)3.5 (2-13)7 (2.5-12.5)4 (1.5-10)
RF (kU/l)a65.1 (34.8-187)63.1 (37.9-146.8)62.1 (29.0-150)93.5 (34.6-259)
RF-positive (%)a62 (87.3)15 (93.8)24 (85.7)23 (85.2)
Anti-CCP (U/ml)b94.1 (31.7-532.3)87.1 (22.4-536.1)91.4 (49.2-501)100.9 (34.8-574)
Anti-CCP-positive (%)b67 (89.3)16 (88.9)26 (89.7)25 (89.3)
CRP (mg/l)C3.0 (0.9-9.9)1.3 (0.8-3.6)2.4 (0.9-9.3)5.1 (1.2-17.3)
CRP positive (%)C20 (28.6)1 (6.7)8 (27.6)11 (42.3)
ESR (mm/h)27 (18-42)19 (11-26)33 (23-46)38 (21.5-51.5)
DAS28-ESR
Medicine use
 NSAIDs16 (20.8)2 (10.5)8 (27.6)6 (20.7)
 DMARDs57 (74.0)17 (89.5)20 (69.0)20 (69.0)
  Methotrexate47 (61.0)15 (78.9)15 (51.7)17 (58.6)
  Leflunomide32 (41.6)10 (52.6)11 (37.9)11 (37.9)
  Sulfasalazine8 (10.4)2 (10.5)5 (17.2)1 (3.4)
 Prednisolone12 (15.6)2 (10.5)3 (10.3)7 (24.1)
 Chinese medicine16 (20.8)4 (21.1)7 (24.1)7 (24.1)
 No treatment7 (9.1)1 (5.3)2 (6.9)4 (13.8)
 Otherd4 (5.2)1 (5.3)2 (6.9)1 (3.4)
 Unknowne4 (5.2)0 (0)1 (3.4)3 (10.3)

The data are expressed as (%), deviation (SD), or median (interquartile range, 25th-75th). DAS28-ESR: Disease Activity Score of 28 joints using ESR; NSAIDs: nonsteroidal anti-inflammatory drugs; DMARDs: disease-modifying antirheumatic drugs. aRF data were lacking in 6 subjects. Sixty-two out of 71 RA subjects were RF-positive. bAnti-CCP data were lacking in 2 subjects. Sixty-seven out of 75 RA subjects were anti-CCP-positive. cCRP data were lacking in 7 subjects. Twenty out of 70 RA subjects were CRP-positive. dThe patients defined as “other” included the following: those who were on their first visit to our hospital, were not on regular medication (one patient), and were taking other medicines that were not related to RA therapy (three patients). eThe patients defined as “unknown” included the following: those who were on their first visit to our hospital, could not tell which medication to use (two patients), and were only told of a few of their medicines (two patients).

References

  1. Y. Zhang, R. Cao, H. Ying et al., “Increased expression of TLR10 in B cell subsets correlates with disease activity in rheumatoid arthritis,” Mediators of Inflammation, vol. 2018, Article ID 9372436, 10 pages, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Ying Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views310
Downloads222
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.